Do analysts recommend CRVL or LMRI?

Lumexa Imaging has a consensus price target of $16.40, suggesting a potential upside of 17.82%. Given Lumexa Imaging's stronger consensus rating and higher probable upside, analysts clearly believe Lumexa Imaging is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorVel 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Lumexa Imaging 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.00

Which has stronger valuation and earnings, CRVL or LMRI?

CorVel has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CorVel $958.53M 4.39 $110.34M $2.38 35.14 Lumexa Imaging $267.73M 4.99 -$47.10M -$0.49 N/A

Does the media favor CRVL or LMRI?

In the previous week, Lumexa Imaging had 6 more articles in the media than CorVel. MarketBeat recorded 11 mentions for Lumexa Imaging and 5 mentions for CorVel. CorVel's average media sentiment score of 0.76 beat Lumexa Imaging's score of 0.00 indicating that CorVel is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CorVel 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lumexa Imaging 2 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor AVAH or LMRI?

In the previous week, Lumexa Imaging had 6 more articles in the media than Aveanna Healthcare. MarketBeat recorded 11 mentions for Lumexa Imaging and 5 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 0.45 beat Lumexa Imaging's score of 0.00 indicating that Aveanna Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aveanna Healthcare 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Lumexa Imaging 2 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor PRVA or LMRI?

In the previous week, Privia Health Group had 10 more articles in the media than Lumexa Imaging. MarketBeat recorded 21 mentions for Privia Health Group and 11 mentions for Lumexa Imaging. Privia Health Group's average media sentiment score of 0.62 beat Lumexa Imaging's score of 0.00 indicating that Privia Health Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Privia Health Group 5 Very Positive mention(s) 3 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lumexa Imaging 2 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to MD or LMRI?

In the previous week, Lumexa Imaging had 9 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 11 mentions for Lumexa Imaging and 2 mentions for Pediatrix Medical Group. Pediatrix Medical Group's average media sentiment score of 0.58 beat Lumexa Imaging's score of 0.00 indicating that Pediatrix Medical Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pediatrix Medical Group 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Lumexa Imaging 2 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor LMRI or NEO?

In the previous week, Lumexa Imaging had 5 more articles in the media than NeoGenomics. MarketBeat recorded 11 mentions for Lumexa Imaging and 6 mentions for NeoGenomics. NeoGenomics' average media sentiment score of 0.18 beat Lumexa Imaging's score of 0.00 indicating that NeoGenomics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lumexa Imaging 2 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NeoGenomics 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Lumexa Imaging (LMRI) Competitors

$13.92 -0.05 (-0.36%)

Closing price 04:00 PM Eastern

Extended Trading

$13.69 -0.23 (-1.65%)

As of 07:34 PM Eastern

Compare

LMRI vs. CRVL, AVAH, PRVA, MD, and NEO

Should you buy Lumexa Imaging stock or one of its competitors? Lumexa Imaging's main competitors and comparable companies include CorVel (CRVL), Aveanna Healthcare (AVAH), Privia Health Group (PRVA), Pediatrix Medical Group (MD), and NeoGenomics (NEO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Lumexa Imaging compare to CorVel?

CorVel (NASDAQ:CRVL) and Lumexa Imaging (NASDAQ:LMRI) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, valuation, earnings, analyst recommendations, institutional ownership and profitability.

In the previous week, Lumexa Imaging had 6 more articles in the media than CorVel. MarketBeat recorded 11 mentions for Lumexa Imaging and 5 mentions for CorVel. CorVel's average media sentiment score of 0.76 beat Lumexa Imaging's score of 0.00 indicating that CorVel is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CorVel	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Lumexa Imaging	2 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Lumexa Imaging has a consensus price target of $16.40, suggesting a potential upside of 17.82%. Given Lumexa Imaging's stronger consensus rating and higher probable upside, analysts clearly believe Lumexa Imaging is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CorVel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	2 Strong Buy rating(s)	3.00

51.4% of CorVel shares are held by institutional investors. 39.7% of CorVel shares are held by company insiders. Comparatively, 0.7% of Lumexa Imaging shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

CorVel has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CorVel	$958.53M	4.39	$110.34M	$2.38	35.14
Lumexa Imaging	$267.73M	4.99	-$47.10M	-$0.49	N/A

CorVel has a net margin of 12.02% compared to Lumexa Imaging's net margin of 0.00%. CorVel's return on equity of 30.20% beat Lumexa Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CorVel	12.02%	30.20%	18.06%
Lumexa Imaging	N/A	N/A	N/A

Summary

CorVel beats Lumexa Imaging on 10 of the 16 factors compared between the two stocks.

How does Lumexa Imaging compare to Aveanna Healthcare?

Aveanna Healthcare (NASDAQ:AVAH) and Lumexa Imaging (NASDAQ:LMRI) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, valuation, profitability, risk and dividends.

In the previous week, Lumexa Imaging had 6 more articles in the media than Aveanna Healthcare. MarketBeat recorded 11 mentions for Lumexa Imaging and 5 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 0.45 beat Lumexa Imaging's score of 0.00 indicating that Aveanna Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aveanna Healthcare	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Lumexa Imaging	2 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Aveanna Healthcare has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aveanna Healthcare	$2.43B	1.18	$225.03M	$1.23	10.72
Lumexa Imaging	$267.73M	4.99	-$47.10M	-$0.49	N/A

88.0% of Aveanna Healthcare shares are owned by institutional investors. 5.3% of Aveanna Healthcare shares are owned by company insiders. Comparatively, 0.7% of Lumexa Imaging shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Aveanna Healthcare presently has a consensus price target of $14.25, indicating a potential upside of 8.04%. Lumexa Imaging has a consensus price target of $16.40, indicating a potential upside of 17.82%. Given Lumexa Imaging's stronger consensus rating and higher probable upside, analysts clearly believe Lumexa Imaging is more favorable than Aveanna Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aveanna Healthcare	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	2 Strong Buy rating(s)	3.00

Aveanna Healthcare has a net margin of 10.56% compared to Lumexa Imaging's net margin of 0.00%. Aveanna Healthcare's return on equity of 80.70% beat Lumexa Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aveanna Healthcare	10.56%	80.70%	7.42%
Lumexa Imaging	N/A	N/A	N/A

Summary

Aveanna Healthcare beats Lumexa Imaging on 11 of the 16 factors compared between the two stocks.

How does Lumexa Imaging compare to Privia Health Group?

Privia Health Group (NASDAQ:PRVA) and Lumexa Imaging (NASDAQ:LMRI) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk, media sentiment and valuation.

In the previous week, Privia Health Group had 10 more articles in the media than Lumexa Imaging. MarketBeat recorded 21 mentions for Privia Health Group and 11 mentions for Lumexa Imaging. Privia Health Group's average media sentiment score of 0.62 beat Lumexa Imaging's score of 0.00 indicating that Privia Health Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Privia Health Group	5 Very Positive mention(s)	3 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Lumexa Imaging	2 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Privia Health Group has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Privia Health Group	$2.12B	1.47	$22.92M	$0.26	93.73
Lumexa Imaging	$267.73M	4.99	-$47.10M	-$0.49	N/A

94.5% of Privia Health Group shares are owned by institutional investors. 5.7% of Privia Health Group shares are owned by insiders. Comparatively, 0.7% of Lumexa Imaging shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Privia Health Group has a net margin of 1.43% compared to Lumexa Imaging's net margin of 0.00%. Privia Health Group's return on equity of 4.20% beat Lumexa Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Privia Health Group	1.43%	4.20%	2.38%
Lumexa Imaging	N/A	N/A	N/A

Privia Health Group presently has a consensus target price of $31.25, indicating a potential upside of 28.23%. Lumexa Imaging has a consensus target price of $16.40, indicating a potential upside of 17.82%. Given Privia Health Group's higher possible upside, analysts plainly believe Privia Health Group is more favorable than Lumexa Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.75
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	2 Strong Buy rating(s)	3.00

Summary

Privia Health Group beats Lumexa Imaging on 13 of the 16 factors compared between the two stocks.

How does Lumexa Imaging compare to Pediatrix Medical Group?

Pediatrix Medical Group (NYSE:MD) and Lumexa Imaging (NASDAQ:LMRI) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, media sentiment, risk, analyst recommendations, valuation and institutional ownership.

Pediatrix Medical Group currently has a consensus target price of $27.20, suggesting a potential downside of 13.80%. Lumexa Imaging has a consensus target price of $16.40, suggesting a potential upside of 17.82%. Given Lumexa Imaging's stronger consensus rating and higher probable upside, analysts clearly believe Lumexa Imaging is more favorable than Pediatrix Medical Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pediatrix Medical Group	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	2 Strong Buy rating(s)	3.00

97.7% of Pediatrix Medical Group shares are held by institutional investors. 1.8% of Pediatrix Medical Group shares are held by company insiders. Comparatively, 0.7% of Lumexa Imaging shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Pediatrix Medical Group has a net margin of 7.66% compared to Lumexa Imaging's net margin of 0.00%. Pediatrix Medical Group's return on equity of 20.12% beat Lumexa Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pediatrix Medical Group	7.66%	20.12%	8.14%
Lumexa Imaging	N/A	N/A	N/A

In the previous week, Lumexa Imaging had 9 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 11 mentions for Lumexa Imaging and 2 mentions for Pediatrix Medical Group. Pediatrix Medical Group's average media sentiment score of 0.58 beat Lumexa Imaging's score of 0.00 indicating that Pediatrix Medical Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pediatrix Medical Group	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Lumexa Imaging	2 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Pediatrix Medical Group has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than Pediatrix Medical Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pediatrix Medical Group	$1.91B	1.29	$165.39M	$1.84	17.15
Lumexa Imaging	$267.73M	4.99	-$47.10M	-$0.49	N/A

Summary

Pediatrix Medical Group beats Lumexa Imaging on 10 of the 16 factors compared between the two stocks.

How does Lumexa Imaging compare to NeoGenomics?

Lumexa Imaging (NASDAQ:LMRI) and NeoGenomics (NASDAQ:NEO) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, earnings and risk.

Lumexa Imaging currently has a consensus price target of $16.40, indicating a potential upside of 17.82%. NeoGenomics has a consensus price target of $20.88, indicating a potential upside of 23.08%. Given NeoGenomics' higher possible upside, analysts clearly believe NeoGenomics is more favorable than Lumexa Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	2 Strong Buy rating(s)	3.00
NeoGenomics	1 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.58

98.5% of NeoGenomics shares are held by institutional investors. 0.7% of Lumexa Imaging shares are held by insiders. Comparatively, 1.1% of NeoGenomics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Lumexa Imaging has a net margin of 0.00% compared to NeoGenomics' net margin of -4.10%. Lumexa Imaging's return on equity of 0.00% beat NeoGenomics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lumexa Imaging	N/A	N/A	N/A
NeoGenomics	-4.10%	-0.99%	-0.59%

In the previous week, Lumexa Imaging had 5 more articles in the media than NeoGenomics. MarketBeat recorded 11 mentions for Lumexa Imaging and 6 mentions for NeoGenomics. NeoGenomics' average media sentiment score of 0.18 beat Lumexa Imaging's score of 0.00 indicating that NeoGenomics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lumexa Imaging	2 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
NeoGenomics	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Lumexa Imaging has higher earnings, but lower revenue than NeoGenomics. NeoGenomics is trading at a lower price-to-earnings ratio than Lumexa Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lumexa Imaging	$267.73M	4.99	-$47.10M	-$0.49	N/A
NeoGenomics	$727.33M	3.02	-$108.03M	-$0.25	N/A

Summary

Lumexa Imaging beats NeoGenomics on 8 of the 15 factors compared between the two stocks.

Get Lumexa Imaging News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LMRI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LMRI vs. The Competition

Export

Metric	Lumexa Imaging	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.34B	$10.70B	$7.90B	$12.09B
Dividend Yield	N/A	2.54%	2.46%	4.43%
P/E Ratio	-28.41	39.67	34.77	28.27
Price / Sales	4.99	2.12	8.83	5.87
Price / Cash	40.18	23.54	22.22	22.66
Price / Book	2.25	3.79	4.40	3.79
Net Income	-$47.10M	$332.46M	$3.50B	$389.59M
7 Day Performance	24.06%	-0.03%	0.05%	-1.14%
1 Month Performance	32.07%	0.47%	-4.54%	-6.70%
1 Year Performance	N/A	20.42%	2.80%	-6.24%

Lumexa Imaging Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LMRI Lumexa Imaging	3.0794 of 5 stars	$13.92 -0.4%	$16.40 +17.8%	N/A	$1.34B	$267.73M	N/A	5,019	News Coverage Earnings Report
CRVL CorVel	1.6281 of 5 stars	$82.19 +0.7%	N/A	+8.2%	$4.16B	$958.53M	36.26	5,239	Earnings Report
AVAH Aveanna Healthcare	4.1838 of 5 stars	$13.26 +1.5%	$14.25 +7.5%	+50.9%	$2.85B	$2.43B	10.78	35,500	Positive News Upcoming Earnings
PRVA Privia Health Group	4.217 of 5 stars	$22.00 +0.7%	$31.00 +40.9%	+4.7%	$2.79B	$2.12B	104.77	1,226	News Coverage Earnings Report
MD Pediatrix Medical Group	2.003 of 5 stars	$29.07 +0.5%	$26.60 -8.5%	+42.9%	$2.35B	$1.91B	13.91	4,315

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LMRI) was last updated on 11/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lumexa Imaging (LMRI) Competitors

LMRI vs. CRVL, AVAH, PRVA, MD, and NEO

How does Lumexa Imaging compare to CorVel?

Summary

How does Lumexa Imaging compare to Aveanna Healthcare?

Summary

How does Lumexa Imaging compare to Privia Health Group?

Summary

How does Lumexa Imaging compare to Pediatrix Medical Group?

Summary

How does Lumexa Imaging compare to NeoGenomics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LMRI vs. The Competition

Lumexa Imaging Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Lumexa Imaging (LMRI) Competitors

LMRI vs. CRVL, AVAH, PRVA, MD, and NEO

How does Lumexa Imaging compare to CorVel?

Does the media favor CRVL or LMRI?

Do analysts recommend CRVL or LMRI?

Do institutionals & insiders hold more shares of CRVL or LMRI?

Which has stronger valuation and earnings, CRVL or LMRI?

Is CRVL or LMRI more profitable?

Summary

How does Lumexa Imaging compare to Aveanna Healthcare?

Does the media favor AVAH or LMRI?

Which has better valuation & earnings, AVAH or LMRI?

Do insiders and institutionals believe in AVAH or LMRI?

Do analysts rate AVAH or LMRI?

Is AVAH or LMRI more profitable?

Summary

How does Lumexa Imaging compare to Privia Health Group?

Does the media favor PRVA or LMRI?

Which has preferable earnings & valuation, PRVA or LMRI?

Do institutionals & insiders believe in PRVA or LMRI?

Is PRVA or LMRI more profitable?

Do analysts recommend PRVA or LMRI?

Summary

How does Lumexa Imaging compare to Pediatrix Medical Group?

Do analysts rate MD or LMRI?

Do insiders & institutionals have more ownership in MD or LMRI?

Is MD or LMRI more profitable?

Does the media refer more to MD or LMRI?

Which has preferable earnings & valuation, MD or LMRI?

Summary

How does Lumexa Imaging compare to NeoGenomics?

Do analysts recommend LMRI or NEO?

Do institutionals and insiders believe in LMRI or NEO?

Is LMRI or NEO more profitable?

Does the media favor LMRI or NEO?

Which has stronger valuation & earnings, LMRI or NEO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LMRI vs. The Competition

Lumexa Imaging Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools